BSC
BIIB icon

BOLTON SECURITIES CORPORATION’s Biogen BIIB Stock Holding History

BOLTON SECURITIES CORPORATION’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$48.1K Buy
213
+5
+2% +$1.06K ﹤0.01% 1353
2026
Q2 		$44.9K Buy
208
+4
+2% +$765 ﹤0.01% 1373
2026
Q1 		$37.4K Buy
+204
New +$37.6K ﹤0.01% 1300
2025
Q3 		$28.6K Buy
+204
New +$27.6K ﹤0.01% 1302
2025
Q1 		$31.3K Buy
+229
New +$32.7K ﹤0.01% 1169

Other funds holding BIIB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $111B AUM 30.48% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return

BOLTON SECURITIES CORPORATION's BIIB Position: Q3 2026 in Review

BOLTON SECURITIES CORPORATION increased its Biogen (BIIB) stake by 2.4% in Q3 2026, buying an estimated $1.06K and bringing the position to 213 shares worth $48.1K. The position accounts for ﹤0.01% of the portfolio, ranked #1353.

BOLTON SECURITIES CORPORATION first reported a position in BIIB in Q1 2025 and has held it in 5 quarters since. 728 funds tracked by Wall St. Rank hold BIIB as of Q3 2026.

  • BOLTON SECURITIES CORPORATION held 213 shares of Biogen worth $48.1K as of Q3 2026.
  • BOLTON SECURITIES CORPORATION bought 5 Biogen shares in Q3 2026, an estimated $1.06K.
  • Biogen made up ﹤0.01% of BOLTON SECURITIES CORPORATION's portfolio in Q3 2026, its #1353 holding.
  • BOLTON SECURITIES CORPORATION first reported a position in Biogen in Q1 2025 and has held it in 5 quarters since.
  • 728 funds tracked by Wall St. Rank held Biogen as of Q3 2026.

Based on BOLTON SECURITIES CORPORATION's 13F filing for Q3 2026, filed 12 Nov 2026.